Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
1.250
+0.300 (31.51%)
At close: Aug 13, 2025, 4:00 PM
1.260
+0.010 (0.80%)
After-hours: Aug 13, 2025, 5:21 PM EDT
Tilray Brands Revenue
In the fiscal year ending May 31, 2025, Tilray Brands had annual revenue of $821.31M with 4.10% growth. Tilray Brands had revenue of $224.54M in the quarter ending May 31, 2025, a decrease of -2.33%.
Revenue (ttm)
$821.31M
Revenue Growth
+4.10%
P/S Ratio
1.03
Revenue / Employee
$288,990
Employees
2,842
Market Cap
1.37B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2025 | 821.31M | 32.37M | 4.10% |
May 31, 2024 | 788.94M | 161.82M | 25.80% |
May 31, 2023 | 627.12M | -1.25M | -0.20% |
May 31, 2022 | 628.37M | 115.29M | 22.47% |
May 31, 2021 | 513.09M | 107.76M | 26.59% |
May 31, 2020 | Pro | Pro | Pro |
May 31, 2019 | Pro | Pro | Pro |
May 31, 2018 | Pro | Pro | Pro |
May 31, 2017 | Pro | Pro | Pro |
May 31, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
TLRY News
- 10 hours ago - Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts - GlobeNewsWire
- 1 day ago - Is Tilray stock price rally a trap? history suggests selling - Invezz
- 1 day ago - Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drinks from Fizzy Jane's and Happy Flower Brands - GlobeNewsWire
- 1 day ago - Tilray Brands: Is TLRY Stock The Next Big Thing? - Forbes
- 2 days ago - Cannabis stocks soar on Trump reclassification speculation - Invezz
- 2 days ago - Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification - CNBC
- 6 days ago - Best Canadian Cannabis Penny Stocks Under $5 to Watch Now - MarijuanaStocks
- 6 days ago - Tilray Brands Launches The Humble Seed Whole Wheat Protein Crackers at Whole Foods Market - GlobeNewsWire